Philadelphia Trust Company’s Novo Nordisk NVO Stock Holding History

Philadelphia Trust Company’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$362K	Hold	7,550	–	–	0.02%	195
2026 Q1	$277K	Buy	7,550 +50	+0.7%	+$2.37K	0.02%	222
2025 Q4	$382K	Hold	7,500	–	–	0.03%	184
2025 Q3	$416K	Hold	7,500	–	–	0.03%	169
2025 Q2	$518K	Hold	7,500	–	–	0.04%	150
2025 Q1	$521K	Hold	7,500	–	–	0.04%	149
2024 Q4	$645K	Hold	7,500	–	–	0.05%	138
2024 Q3	$893K	Hold	7,500	–	–	0.06%	127
2024 Q2	$1.07M	Hold	7,500	–	–	0.08%	111
2024 Q1	$963K	Hold	7,500	–	–	0.08%	119
2023 Q4	$776K	Hold	7,500	–	–	0.07%	123
2023 Q3	$682K	Hold	7,500	–	–	0.07%	129
2023 Q2	$607K	Hold	7,500	–	–	0.06%	143
2023 Q1	$597K	Hold	7,500	–	–	0.06%	142
2022 Q4	$508K	Hold	7,500	–	–	0.05%	150
2022 Q3	$374K	Hold	7,500	–	–	0.04%	168
2022 Q2	$418K	Hold	7,500	–	–	0.04%	157
2022 Q1	$416K	Hold	7,500	–	–	0.03%	178
2021 Q4	$420K	Hold	7,500	–	–	0.03%	183
2021 Q3	$360K	Hold	7,500	–	–	0.03%	188
2021 Q2	$314K	Hold	7,500	–	–	0.02%	202
2021 Q1	$253K	Hold	7,500	–	–	0.02%	204
2020 Q4	$262K	Hold	7,500	–	–	0.02%	193
2020 Q3	$260K	Buy	+7,500	New	+$250K	0.03%	180
2015 Q3	–	Sell	-510	Closed	-$4.66K	–	179
2015 Q2	$4.66K	Buy	+510	New	+$14.3K	0.02%	166

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Philadelphia Trust Company's NVO Position: Q2 2026 in Review

Philadelphia Trust Company held its Novo Nordisk (NVO) position steady in Q2 2026 at 7,550 shares worth $362K. The position accounts for 0.02% of the portfolio, ranked #195.

Philadelphia Trust Company first reported a position in NVO in Q2 2015 and has held it in 25 quarters since. The position peaked at $1.07M in Q2 2024. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Philadelphia Trust Company held 7,550 shares of Novo Nordisk worth $362K as of Q2 2026.
Philadelphia Trust Company left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.02% of Philadelphia Trust Company's portfolio in Q2 2026, its #195 holding.
Philadelphia Trust Company first reported a position in Novo Nordisk in Q2 2015 and has held it in 25 quarters since.
Philadelphia Trust Company's Novo Nordisk position peaked at $1.07M in Q2 2024.
1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Philadelphia Trust Company's 13F filing for Q2 2026, filed 10 Aug 2026.